Swiss drugmaker Novartis to buy Avidity Biosciences for $12 billion

finance.yahoo.com/news/swiss-drugmaker-novartis-buy-avidity-194333840.html

Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash, as the company looks to bolster its portfolio of treatments for rare muscle disorders.
As per the terms of the deal, Avidity stockholders will receive $72 per…

This story appeared on finance.yahoo.com, 2025-10-26 19:43:33.
The Entire Business World on a Single Page. Free to Use →